We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, N.I.H., EXTRAMURAL
REVIEW
Screening for HIV in pregnant women: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.
Annals of Internal Medicine 2012 November 21
BACKGROUND: A 2005 U.S. Preventive Services Task Force (USPSTF) review found good evidence that prenatal HIV screening is accurate and can lead to interventions that reduce the risk for mother-to-child transmission.
PURPOSE: To update the 2005 USPSTF review, focusing on previously identified research gaps and new evidence on treatments.
DATA SOURCES: MEDLINE (2004 to June 2012) and the Cochrane Library (2005 to the second quarter of 2012).
STUDY SELECTION: Randomized trials and cohort studies of pregnant women on risk for mother-to-child transmission or harms associated with prenatal HIV screening or antiretroviral therapy during pregnancy.
DATA EXTRACTION: 2 reviewers abstracted and confirmed study details and quality by using predefined criteria.
DATA SYNTHESIS: No studies directly evaluated effects of prenatal HIV screening on risk for mother-to-child transmission or maternal or infant clinical outcomes. One fair-quality, large cohort study (HIV prevalence, 0.7%) found that rapid testing during labor was associated with a positive predictive value of 90%. New cohort studies of nonbreastfeeding women in the United States and Europe confirm that full-course combination antiretroviral therapy reduces rates of mother-to-child transmission (<1% to 2.4% vs. 9% to 22% with no antiretroviral therapy). New cohort studies found antiretroviral therapy during pregnancy to be associated with increased risk for preterm delivery (<37 weeks' gestation); there were no clear associations with low birthweight, congenital abnormalities, or infant neurodevelopment. Evidence on long-term maternal harms after short-term antiretroviral therapy exposure during pregnancy remains sparse.
LIMITATIONS: Only English-language articles were included. Studies conducted in resource-poor settings may be of limited applicability to screening in the United States.
CONCLUSION: Antiretroviral therapy in combination with avoidance of breastfeeding and elective cesarean section in women with viremia reduces risk for mother-to-child transmission. Use of certain antiretroviral therapy regimens during pregnancy may increase risk for preterm delivery.
PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.
PURPOSE: To update the 2005 USPSTF review, focusing on previously identified research gaps and new evidence on treatments.
DATA SOURCES: MEDLINE (2004 to June 2012) and the Cochrane Library (2005 to the second quarter of 2012).
STUDY SELECTION: Randomized trials and cohort studies of pregnant women on risk for mother-to-child transmission or harms associated with prenatal HIV screening or antiretroviral therapy during pregnancy.
DATA EXTRACTION: 2 reviewers abstracted and confirmed study details and quality by using predefined criteria.
DATA SYNTHESIS: No studies directly evaluated effects of prenatal HIV screening on risk for mother-to-child transmission or maternal or infant clinical outcomes. One fair-quality, large cohort study (HIV prevalence, 0.7%) found that rapid testing during labor was associated with a positive predictive value of 90%. New cohort studies of nonbreastfeeding women in the United States and Europe confirm that full-course combination antiretroviral therapy reduces rates of mother-to-child transmission (<1% to 2.4% vs. 9% to 22% with no antiretroviral therapy). New cohort studies found antiretroviral therapy during pregnancy to be associated with increased risk for preterm delivery (<37 weeks' gestation); there were no clear associations with low birthweight, congenital abnormalities, or infant neurodevelopment. Evidence on long-term maternal harms after short-term antiretroviral therapy exposure during pregnancy remains sparse.
LIMITATIONS: Only English-language articles were included. Studies conducted in resource-poor settings may be of limited applicability to screening in the United States.
CONCLUSION: Antiretroviral therapy in combination with avoidance of breastfeeding and elective cesarean section in women with viremia reduces risk for mother-to-child transmission. Use of certain antiretroviral therapy regimens during pregnancy may increase risk for preterm delivery.
PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.
Full text links
Related Resources
Trending Papers
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app